TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 380 filers reported holding TANDEM DIABETES CARE INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9 | -25.0% | 450 | -5.3% | 0.00% | – |
Q2 2023 | $12 | -82.1% | 475 | -71.4% | 0.00% | – |
Q1 2023 | $67 | -5.6% | 1,659 | +5.7% | 0.00% | -100.0% |
Q4 2022 | $71 | -99.7% | 1,570 | +196.2% | 0.00% | – |
Q3 2022 | $25,000 | -59.7% | 530 | -49.1% | 0.00% | – |
Q2 2022 | $62,000 | -3.1% | 1,041 | +88.2% | 0.00% | – |
Q1 2022 | $64,000 | -5.9% | 553 | +21.5% | 0.00% | – |
Q4 2021 | $68,000 | +325.0% | 455 | +174.1% | 0.00% | – |
Q2 2021 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q1 2021 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q4 2020 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q3 2020 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q2 2020 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q1 2020 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q4 2019 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q3 2019 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q2 2019 | $16,000 | 0.0% | 166 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | +300.0% | 166 | +55.1% | 0.00% | – |
Q4 2018 | $4,000 | – | 107 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |